发明名称 Dosage of oligonucleotides suitable for the treatment of tumors
摘要 A method for preventing and/or treating a tumor, the method comprising: intravenously administering an antisense oligonucleotide in an amount of between about 400 to about 800 mg/m2/treatment cycle, the antisense oligonucleotide comprises 8 to 30 nucleotide building blocks, which hybridizes with mRNA of TGF-beta-2, -1 and/or -3 for the preparation of a pharmaceutical composition.
申请公布号 US8822425(B2) 申请公布日期 2014.09.02
申请号 US200912453487 申请日期 2009.05.12
申请人 Antisense Pharma GmbH 发明人 Schlingensiepen Karl-Hermann;Heinrichs Hubert;Schmaus Susanne
分类号 C12N15/11;C07H21/04 主分类号 C12N15/11
代理机构 Jacobson Holman, PLLC. 代理人 Jacobson Holman, PLLC.
主权项 1. A method for treating pancreatic carcinoma or malignant melanoma consisting of: intravenously administering only an antisense oligonucleotide of sequence SEQ ID NO: 22 in an amount of between about 400 to about 800 mg/m2/treatment cycle, wherein a treatment cycle consists of an administration cycle that is the time taken for a first administration of about 400 to about 800 mg/m2 of the oligonucleotide, and, if any further administration cycle is performed, the time interval between consecutive administration cycles.
地址 Regensburg DE